La Jolla Pharmaceutical Company (LJPC) Stock Analysis
DELISTED 2010
What happened to La Jolla Pharmaceutical Company (LJPC) stock?
La Jolla Pharmaceutical Company (LJPC) no longer trades on public markets. It was delisted in March 2010. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- March 2010
- Last recorded price (historical):
- $6.19 (last quote on record before the March 2010 delisting; historical, not a current quote)
P/E 10.67 means the share price is 10.67 times one year of earnings per share.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
La Jolla Pharmaceutical Company (LJPC). La Jolla Pharmaceutical Company develops and commercializes therapies for life-threatening diseases, including GIAPREZA for septic shock and XERAVA for complicated intra-abdominal infections.
Last analyzed: Jun 15, 2026La Jolla Pharmaceutical Company (LJPC) Healthcare & Pipeline Overview
More about this archive record
Can I still buy LJPC shares?
No. LJPC stopped trading on public markets in March 2010, so the shares are not available through a broker. Anything you see quoted for LJPC elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before LJPC stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to La Jolla Pharmaceutical Company. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.